| Follow-up of adults with noncritical COVID-19 two months after symptom onset C Carvalho-Schneider, E Laurent, A Lemaignen, E Beaufils, ... Clinical microbiology and infection 27 (2), 258-263, 2021 | 953 | 2021 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 574 | 2017 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 544 | 2021 |
| Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? M Gousseff, P Penot, L Gallay, D Batisse, N Benech, K Bouiller, ... Journal of Infection 81 (5), 816-846, 2020 | 357 | 2020 |
| Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation A Lemaignen, G Birgand, W Ghodhbane, S Alkhoder, I Lolom, S Belorgey, ... Clinical Microbiology and Infection 21 (7), 674. e11-674. e18, 2015 | 225 | 2015 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 175 | 2022 |
| Mpox in people with past infection or a complete vaccination course: a global case series A Hazra, J Zucker, E Bell, J Flores, L Gordon, O Mitjà, C Suñer, ... The Lancet Infectious Diseases 24 (1), 57-64, 2024 | 101 | 2024 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 91 | 2021 |
| Dolutegravir monotherapy versus dolutegravir/abacavir/lamivudine for virologically suppressed people living with chronic human immunodeficiency virus infection: the randomized … L Hocqueloux, F Raffi, T Prazuck, L Bernard, S Sunder, JL Esnault, D Rey, ... Clinical Infectious Diseases 69 (9), 1498-1505, 2019 | 74 | 2019 |
| Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study A Lemaignen, I Ghout, A Dinh, G Gras, B Fantin, V Zarrouk, R Carlier, ... Medicine 96 (21), e6387, 2017 | 73 | 2017 |
| Incidence, characteristics, and mortality of infective endocarditis in France in 2011 S Sunder, L Grammatico-Guillon, A Lemaignen, M Lacasse, C Gaborit, ... PLoS One 14 (10), e0223857, 2019 | 64 | 2019 |
| Clinical and Biological Characteristics of 40 Patients With Neurosyphilis and Evaluation of Treponema pallidum Nested Polymerase Chain Reaction in … C Vanhaecke, P Grange, N Benhaddou, P Blanche, D Salmon, P Parize, ... Clinical Infectious Diseases 63 (9), 1180-1186, 2016 | 60 | 2016 |
| Pyogenic vertebral osteomyelitis of the elderly: characteristics and outcomes J Courjon, A Lemaignen, I Ghout, A Therby, N Belmatoug, A Dinh, G Gras, ... PLoS One 12 (12), e0188470, 2017 | 58 | 2017 |
| ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 51 | 2022 |
| Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort S Tubiana, E Varon, C Biron, MC Ploy, B Mourvillier, MK Taha, M Revest, ... Clinical Microbiology and Infection 26 (9), 1192-1200, 2020 | 51 | 2020 |
| Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice B Aloy, V Launay-Vacher, A Bleibtreu, P Bortolotti, E Faure, A Filali, ... Medecine et maladies infectieuses 50 (4), 323-331, 2020 | 42 | 2020 |
| Impact of Enterococcus faecalis Endocarditis Treatment on Risk of Relapse P Danneels, JF Hamel, L Picard, S Rezig, P Martinet, A Lorleac’h, ... Clinical Infectious Diseases 76 (2), 281-290, 2023 | 41 | 2023 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 40 | 2021 |
| Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised … AJ Kaasch, LE López-Cortés, J Rodríguez-Baño, JM Cisneros, ... The Lancet Infectious Diseases 24 (5), 523-534, 2024 | 39 | 2024 |
| A new mechanism of resistance of human immunodeficiency virus type 2 to integrase inhibitors: a 5-amino-acid insertion in the integrase C-terminal domain Q Le Hingrat, G Collin, M Lê, G Peytavin, B Visseaux, M Bertine, ... Clinical Infectious Diseases 69 (4), 657-667, 2019 | 36 | 2019 |